Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDewhurst Regulatory News (DWHT)

Share Price Information for Dewhurst (DWHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,185.00
Bid: 1,170.00
Ask: 1,200.00
Change: 0.00 (0.00%)
Spread: 30.00 (2.564%)
Open: 1,185.00
High: 1,185.00
Low: 1,185.00
Prev. Close: 1,185.00
DWHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Trading Update

31 Mar 2020 07:00

RNS Number : 1331I
Dewhurst PLC
31 March 2020
 

31 March 2020

 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Dewhurst PLC

 

("Dewhurst", the "Group" or the "Company")

 

COVID-19 Trading Update

 

 

In the light of the rapidly evolving situation resulting from the spread of COVID-19 and its development into a global pandemic, Dewhurst today provides an update on current trading and operations. Our priority remains the health, safety and well-being of our employees and essential support for our customers.

 

Current Trading and Operations

 

In the first five months of the current financial year to 29 February 2020 there was no material COVID-19 impact on overall Group trading, although Hong Kong revenues started to be affected. During March Dewhurst saw the impact gradually spread to other locations. Overall first half revenues are now expected to be approximately £28 million (HY19 revenue: £28 million, restated to exclude TVC which was sold on 30 September 2019).

 

Employees and customers

 

Our overriding objective is to maintain the safety of our employees. We have followed national and, where appropriate, regional government advice and restrictions in the countries where we operate. However, where it has been deemed safe to do so, the Company has continued its sales and manufacturing operations in order to provide support to our customers. This is gradually getting more difficult. International travel and transport are severely restricted, which affects our ability to resupply our overseas operations with components. We are reviewing our arrangements from day to day as, clearly, the situation is fast changing. We are operating flexible working arrangements wherever possible and have increased the provision of equipment to enable office-based employees to work from home. We have restricted travel and face-to-face meetings but maintained employee contact through increased use of Office 365 Teams and other conferencing facilities. We have enforced health and hygiene practices and are regularly reinforcing and reminding employees of these protocols.

 

Board Actions Taken

 

Clearly the main concern beyond employee welfare and customer support is the impact of the COVID-19 pandemic on the long-term security of the Group. To mitigate the effects of the pandemic the Board has made several decisions to reduce costs and contain cash outflow including the following:

 

· Over the last week it became increasingly difficult for Dewhurst UK to maintain normal production as more of its suppliers and customers closed their doors and staff numbers reduced due to staff self-isolating at home. Accordingly, Dewhurst has taken the decision to close operations at Dewhurst UK. In the UK, A&A and TMP currently remain open albeit with a reduced workforce. It is anticipated that similar action may become necessary in the Group's other operations in time, if greater restrictions come into force in other countries in which the Group operates.

 

· We are restricting discretionary spending and non-committed capital expenditure. For now, the development of Dupar's new premises discussed in the 2019 financial statements is continuing as this was contracted and committed to at the start of 2020 but pause points within the construction contract will be regularly reviewed.

 

· We are considering appropriate cost saving initiatives, whilst seeking to protect our talented workforce and being careful not to compromise the long-term prospects of the business.

 

· We are also evaluating and, where sensible, implementing government support measures available in the jurisdictions in which we operate.

 

 

Strong Cash Balance Sheet

 

Dewhurst has a strong balance sheet, is well financed and remains debt free and is therefore well positioned to navigate the COVID-19 pandemic. The Group had c.£17m of cash as at 30 September 2019 and cash flow in the first six months of the year was in line with management's expectations. We currently expect to have sufficient liquidity from existing resources to meet our needs through the remainder of this financial year.

 

Dividends

 

The Board hopes to maintain Dewhurst's dividend policy for the year ending 30 September 2020, however this will depend on the length and severity of business disruption and the outlook for the remainder of the year. We will make a decision on whether this is sustainable at the normal time on the announcement of our half year results.

 

Outlook

 

Given the unprecedented levels of uncertainty at this time and the lack of clarity on the duration of business interruption, all previous guidance on the Group's future performance is being withdrawn. An update will be provided once there is greater certainty on the trading environment and the impact of COVID-19 on the Group. The Board remains confident in the long-term strong business fundamentals of the Group.

 

For further details please contact:

 

Dewhurst Plc

Tel: +44 (0) 208 744 8200

Richard Dewhurst, Chairman

Jared Sinclair, Finance Director

www.dewhurst.plc.uk

 

 

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

David Foreman / Will Goode (Corporate Finance)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDGGDXGXXDGGG
Date   Source Headline
29th Apr 202411:32 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSTransaction in Own Shares and Buyback Update
27th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20246:10 pmRNSAIM Rule 17 Schedule Two (g) Update
26th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20248:33 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSAcquisition of Minority Interest in P&R Liftcars
20th Feb 20244:32 pmRNSResult of AGM
9th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSShare Buyback Programme
1st Feb 20247:00 amRNSHolding(s) in Company
18th Jan 20244:45 pmRNSHolding(s) in Company
12th Jan 202411:31 amRNSHolding(s) in Company
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSDirector / PCA Dealing
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSDisplays and Position Indicators
26th Jun 20237:00 amRNSInterim Results
14th Feb 20235:07 pmRNSResult of AGM
14th Dec 20221:14 pmRNSDirector / PDMR Dealing
8th Dec 20227:00 amRNSPreliminary Results
12th Jul 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 202211:51 amRNSDirector / PDMR Dealing
15th Jun 20227:00 amRNSInterim Results
1st Jun 20227:00 amRNSCyber Incident
1st Mar 20227:00 amRNSChange of Company Name
15th Feb 20224:56 pmRNSResult of AGM and GM
28th Jan 20227:00 amRNSNotice of General Meeting, Proposed Name Change
12th Jan 202211:05 amRNSSecond Price Monitoring Extn
12th Jan 202211:00 amRNSPrice Monitoring Extension
8th Dec 20217:00 amRNSPreliminary Results
8th Jul 20214:33 pmRNSDirector/PDMR Shareholding
15th Jun 20214:46 pmRNSDirector / PDMR Dealing
9th Jun 20218:00 amRNSAppointment of Non-Executive Directors
9th Jun 20217:00 amRNSInterim Results
16th Feb 202112:00 pmRNSResult of AGM
1st Feb 20217:00 amRNSBoard Changes
13th Jan 202111:51 amRNSPosting of Annual Report and Notice of AGM
9th Dec 20207:00 amRNSPreliminary Results
30th Jul 20207:00 amRNSChange of Adviser
3rd Jul 20204:47 pmRNSTransaction in Own Shares
26th Jun 202012:00 pmRNSDirector Resignation
4th Jun 20207:00 amRNSInterim Results
31st Mar 20207:00 amRNSCOVID-19 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.